Nanoparticles Behave Differently in Male and Female Bodies

Silica nanoparticles—widely used in cosmetics, coatings, and drug delivery—interact with blood proteins in distinctly different ways depending on a patient's sex. The finding suggests that safety testing and dosing for nanoparticle-based products may need to account for biological sex, potentially affecting how regulators approve and physicians prescribe these increasingly common treatments.

Originaltitel: Sex-Specific Silica Nanoparticle Protein Corona Compositions Exposed to Male and Female BALB/c Mice Plasmas